ARMANDO ANIDO

Corporate Board Profile

Tech Score: 0/100

SCYNEXIS INC

Filing Date	Source Excerpt
2019-05-07	Mr. Anido has more than 30 years of executive, operational and commercial leadership experience in the biopharmaceutical industry. Prior to Zynerba, Mr. Anido served as CEO of two publicly traded companies.
2020-05-29	Mr. Anido has served as Chairman of the board of directors and Chief Executive Officer of Zynerba Pharmaceuticals... Mr. Anido earned a BS in Pharmacy and an MBA from West Virginia University.
2021-04-26	Mr. Anido earned a BS in Pharmacy and an MBA from West Virginia University. Because of Mr. Anido’s extensive executive, operational, and commercial leadership in the biopharmaceutical industry, we believe he is able to make valuable contributions to our Board of Directors.
2022-05-12	Mr. Anido earned a BS in Pharmacy and an MBA from West Virginia University. Because of Mr. Anido’s extensive executive, operational, and commercial leadership in the biopharmaceutical industry, we believe he is able to make valuable contributions to our Board of Directors.
2022-08-19	Armando Anido
2023-05-01	Mr. Anido has more than 30 years of executive, operational and commercial leadership experience in the biopharmaceutical industry. Prior to Zynerba, Mr. Anido served as CEO of two publicly traded companies.
2024-04-25	Mr. Anido earned a BS in Pharmacy and an MBA from West Virginia University. Because of Mr. Anido’s extensive executive, operational, and commercial leadership in the biopharmaceutical industry, we believe he is able to make valuable contributions to our Board of Directors.

Vaxart, Inc.

Filing Date	Source Excerpt
2015-09-30	Armando Anido, age 57, has served as a member of the Company’s Board of Directors since September 2015.
2016-09-27	Armando Anido, age 58, has served as a member of the Company’s Board of Directors since September 2015 and has been the Chair of the Compensation Committee since November 2015. ... Mr. Anido’s broad understanding of key issues in the biotechnology industry, including sales and marketing, development and commercialization, strategy, and operations and his extensive executive experience in senior leadership and director roles at several biotechnology companies led to the conclusion that he should serve on the Company’s Board of Directors.

Filing Date

Source Excerpt

2015-09-30

Armando Anido, age 57, has served as a member of the Company’s Board of Directors since September 2015.

2016-09-27

Armando Anido, age 58, has served as a member of the Company’s Board of Directors since September 2015 and has been the Chair of the Compensation Committee since November 2015. ... Mr. Anido’s broad understanding of key issues in the biotechnology industry, including sales and marketing, development and commercialization, strategy, and operations and his extensive executive experience in senior leadership and director roles at several biotechnology companies led to the conclusion that he should serve on the Company’s Board of Directors.

Data sourced from SEC filings. Last updated: 2026-02-03